Cargando…

In Vitro Selection of Mutant HDM2 Resistant to Nutlin Inhibition

HDM2 binds to the p53 tumour suppressor and targets it for proteosomal degradation. Presently in clinical trials, the small molecule Nutlin-3A competitively binds to HDM2 and abrogates its repressive function. Using a novel in vitro selection methodology, we simulated the emergence of resistance by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Siau Jia, Joseph, Thomas, Sim, Adelene Y. L., Yurlova, Larisa, Zolghadr, Kourosh, Lane, David, Verma, Chandra, Ghadessy, Farid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641235/ https://www.ncbi.nlm.nih.gov/pubmed/23653682 http://dx.doi.org/10.1371/journal.pone.0062564

Ejemplares similares

Inhibition of Nutlin-Resistant HDM2 Mutants by Stapled Peptides
por: Wei, Siau Jia, et al.
Publicado: (2013)

Binding of Translationally Controlled Tumour Protein to the N-Terminal Domain of HDM2 Is Inhibited by Nutlin-3
por: Funston, Garth, et al.
Publicado: (2012)

Avoiding drug resistance through extended drug target interfaces: a case for stapled peptides
por: Wei, Siau Jia, et al.
Publicado: (2016)

Structure of a Stapled Peptide Antagonist Bound to Nutlin-Resistant Mdm2
por: Chee, Sharon Min Qi, et al.
Publicado: (2014)

Simulations of mutant p53 DNA binding domains reveal a novel druggable pocket
por: Pradhan, Mohan R, et al.
Publicado: (2019)

HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas
por: Sosin, Angela M, et al.
Publicado: (2012)

Functional characterization of p53 pathway components in the ancient metazoan Trichoplax adhaerens
por: Siau, Jia Wei, et al.
Publicado: (2016)

Development and application of a transcriptional sensor for detection of heterologous acrylic acid production in E. coli
por: Raghavan, Sarada S., et al.
Publicado: (2019)

Nutlin‐3a selects for cells harbouring TP 53 mutations
por: Kucab, Jill E., et al.
Publicado: (2016)

Selection of bacteriophage λ integrases with altered recombination specificity by in vitro compartmentalization
por: Tay, Yvonne, et al.
Publicado: (2010)

A New Nanobody-Based Biosensor to Study Endogenous PARP1 In Vitro and in Live Human Cells
por: Buchfellner, Andrea, et al.
Publicado: (2016)

Heterogeneous Mechanisms of Secondary Resistance and Clonal Selection in Sarcoma during Treatment with Nutlin
por: Laroche, Audrey, et al.
Publicado: (2015)

Nutlin-3 sensitizes nasopharyngeal carcinoma cells to cisplatin-induced cytotoxicity
por: VOON, YEE-LIN, et al.
Publicado: (2015)

Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma
por: Zheng, Tongsen, et al.
Publicado: (2014)

Searches for 2HDM at the LHC
por: Chakraborty, Dhiman
Publicado: (2014)

HDM2 ERKs PCNA
por: Nguyen, Hai Dang, et al.
Publicado: (2010)

Searches for 2HDM at the LHC
por: Koehlmann, S
Publicado: (2013)

The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans
por: Coffill, Cynthia R., et al.
Publicado: (2016)

Nutlin-3a for age-related macular degeneration
por: Chung, Hyewon, et al.
Publicado: (2022)

An evaluation in vitro of the efficacy of nutlin-3 and topotecan in combination with (177)Lu-DOTATATE for the treatment of neuroblastoma
por: Tesson, Mathias, et al.
Publicado: (2018)

Allosteric changes in HDM2 by the ATM phosphomimetic S395D mutation: implications on HDM2 function
por: Uhrik, Lukas, et al.
Publicado: (2019)

On the mass and the matter state of the HDM neutrinos
por: Huang Wu Liang
Publicado: (1994)

Exotic or 2HDM Higgs at LEP
por: Kiiskinen, A P
Publicado: (2001)

Higgs EFT for 2HDM and beyond
por: Bélusca-Maïto, Hermès, et al.
Publicado: (2017)

Awakening p53 in senescent cells using nutlin-3
por: Schug, Thaddeus T.
Publicado: (2009)

Hdm2 is an Ubiquitin Ligase of Ku70 -Akt Promotes Cell Survival by Inhibiting Hdm2-dependent Ku70 Destabilization
por: Gama, Vivian, et al.
Publicado: (2009)

2HDM-based and SUSY-inspired models
por: Cortes-Gonzalez, Arely
Publicado: (2018)

A Spiroligomer α-Helix Mimic That Binds HDM2, Penetrates Human Cells and Stabilizes HDM2 in Cell Culture
por: Brown, Zachary Z., et al.
Publicado: (2012)

Nutlin-3a Decreases Male Fertility via UQCRC2
por: Shukla, Kamla Kant, et al.
Publicado: (2013)

New hope for Nutlin-3a therapy for pulmonary arterial hypertension
por: Fukumoto, Jutaro, et al.
Publicado: (2013)

Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment
por: Grillone, Agostina, et al.
Publicado: (2019)

Directed co-evolution of interacting protein–peptide pairs by compartmentalized two-hybrid replication (C2HR)
por: Siau, Jia Wei, et al.
Publicado: (2020)

Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival()
por: Mullany, Lisa K., et al.
Publicado: (2015)

Structure-activity studies of Mdm2/Mdm4-binding stapled peptides comprising non-natural amino acids
por: Chee, Sharon Min Qi, et al.
Publicado: (2017)

2HDM scenario, H to hh and A to Zh
por: CMS Collaboration
Publicado: (2013)

2HDM Neutral Higgs Future Analysis Studies
por: CMS Collaboration
Publicado: (2013)

3HDM with ∆(27) symmetry and its phenomenological consequences
por: Kalinowski, J., et al.
Publicado: (2021)

A less simplified model: 2HDM+pseudoscalar
por: Bjoerke, Kristian
Publicado: (2020)

Topology independent comparison of RNA 3D structures using the CLICK algorithm
por: Nguyen, Minh N., et al.
Publicado: (2017)

MDM2 inhibitors, nutlin-3a and navtemadelin, retain efficacy in human and mouse cancer cells cultured in hypoxia
por: Lerma Clavero, Ada, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_588p596q1ve38ldvancibsq982